REGN Regeneron Pharmaceuticals, Inc.
$945.53
Regeneron Pharmaceuticals, Inc. (REGN) Earnings News
Earnings press releases, previews and reviews for Regeneron Pharmaceuticals, Inc. (REGN), newest first. Our most recent is review: Regeneron's Sanofi Windfall Drives a 19.5% Beat, but the Retinal Franchise Is Still Treading Water.
Friday
October 30, 2026
12:29 PM ET
Regeneron's Sanofi Windfall Drives a 19.5% Beat, but the Retinal Franchise Is Still Treading Water
Earnings Whispers · Review
Friday
October 30, 2026
6:30 AM ET
Regeneron Reports Third Quarter 2026 Financial and Operating Results
Thursday
October 22, 2026
8:22 AM ET
Regeneron's First Full Sanofi Profit Share Meets an Eylea Biosimilar Test
Earnings Whispers · Preview
Thursday
September 24, 2026
4:05 PM ET
Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026
Thursday
July 30, 2026
6:30 AM ET
Regeneron Reports Second Quarter 2026 Financial and Operating Results
Thursday
June 25, 2026
4:05 PM ET
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast